

Cover Story
NCI Director's Report
By Matthew Bin Han Ong
NCI is asking for an appropriation of $7.8 billion for fiscal year 2023—about $800 million above the House’s FY22 proposed budget for NCI.
In Brief


Clinical Roundup


Drugs & Targets
Trending Stories
- Right-wing provocateur Laura Loomer comes for FDA’s Vinay Prasad
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
- Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties
- Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?
- Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out